AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
ECTEINASCIDIN-743, A NEW MARINE NATURAL PRODUCT WITH POTENT ANTITUMOR-ACTIVITY ON HUMAN OVARIAN-CARCINOMA XENOGRAFTS
Authors: VALOTI G NICOLETTI MI PELLEGRINO A JIMENO J HENDRIKS H DINCALCI M FAIRCLOTH G GIAVAZZI R
Citation: G. Valoti et al., ECTEINASCIDIN-743, A NEW MARINE NATURAL PRODUCT WITH POTENT ANTITUMOR-ACTIVITY ON HUMAN OVARIAN-CARCINOMA XENOGRAFTS, Clinical cancer research, 4(8), 1998, pp. 1977-1983
ECTEINASCIDIN-743 (ET-743), A MARINE NATURAL COMPOUND, SHOWS ANTITUMOR-ACTIVITY AGAINST HUMAN OVARIAN-CARCINOMA XENOGRAFTS
Authors: VALOTI G NICOLETTI MI JIMENO J FAIRCLOTH G GIAVAZZI R
Citation: G. Valoti et al., ECTEINASCIDIN-743 (ET-743), A MARINE NATURAL COMPOUND, SHOWS ANTITUMOR-ACTIVITY AGAINST HUMAN OVARIAN-CARCINOMA XENOGRAFTS, European journal of cancer, 34, 1998, pp. 179-179
IN-VITRO ANTITUMOR-ACTIVITY OF THE NOVEL MARINE AGENT, ECTEINASCIDIN-743 (ET-743, NSC-648766) AGAINST HUMAN TUMORS EXPLANTED FROM PATIENTS
Authors: IZBICKA E LAWRENCE R RAYMOND E ECKHARDT G FAIRCLOTH G JIMENO J CLARK G VONHOFF DD
Citation: E. Izbicka et al., IN-VITRO ANTITUMOR-ACTIVITY OF THE NOVEL MARINE AGENT, ECTEINASCIDIN-743 (ET-743, NSC-648766) AGAINST HUMAN TUMORS EXPLANTED FROM PATIENTS, Annals of oncology, 9(9), 1998, pp. 981-987
IN-VITRO SCHEDULE-DEPENDENCY OF MYELOTOXICITY AND CYTOTOXICITY OF ECTEINASCIDIN 743 (ET-743)
Authors: GHIELMINI M COLLI E ERBA E BERGAMASCHI D PAMPALLONA S JIMENO J FAIRCLOTH G SESSA C
Citation: M. Ghielmini et al., IN-VITRO SCHEDULE-DEPENDENCY OF MYELOTOXICITY AND CYTOTOXICITY OF ECTEINASCIDIN 743 (ET-743), Annals of oncology, 9(9), 1998, pp. 989-993
A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF ET-743, A NOVEL MINOR-GROOVE BINDER OF MARINE ORIGIN ADMINISTERED ON A DAILY X 5 SCHEDULE
Authors: HIDALGO M VILLALONACALERO MA ECKHARDT SG WEISS G CAMPBELL E KRAYNAK M BEIJNEN J JIMENO J VONHOFF D ROWINSKY E
Citation: M. Hidalgo et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF ET-743, A NOVEL MINOR-GROOVE BINDER OF MARINE ORIGIN ADMINISTERED ON A DAILY X 5 SCHEDULE, Annals of oncology, 9, 1998, pp. 613-613
ECTEINASCIDIN-743 (ET-743) 24 HOURS CONTINUOUS-INFUSION (CI) - CLINICAL AND PHARMACOKINETIC PHASE-I STUDY PROGRESSIVE REPORT
Authors: RIOFRIO M TAAMMA A MCKRANTER B GOLDWASSER F JIMENO J JASMIN C MISSET JL CVITKOVIC E
Citation: M. Riofrio et al., ECTEINASCIDIN-743 (ET-743) 24 HOURS CONTINUOUS-INFUSION (CI) - CLINICAL AND PHARMACOKINETIC PHASE-I STUDY PROGRESSIVE REPORT, Annals of oncology, 9, 1998, pp. 639-639
IN-VITRO SCHEDULE-DEPENDENT CYTOXICITY BY ECTEINASCIDIN 743 (ET-743) AGAINST HUMAN TUMOR-CELLS
Authors: GRAVALOS MDG LAZARO PR FAIRCLOTH GT JIMENO J SANCHEZ JJ
Citation: Mdg. Gravalos et al., IN-VITRO SCHEDULE-DEPENDENT CYTOXICITY BY ECTEINASCIDIN 743 (ET-743) AGAINST HUMAN TUMOR-CELLS, Annals of oncology, 9, 1998, pp. 652-652
PRECLINICAL DEVELOPMENT OF APLIDINE, A NOVEL MARINE-DERIVED AGENT WITH POTENT ANTITUMOR-ACTIVITY
Authors: FAIRCLOTH G GRANT W NAM S JIMENO J MANZANARES I RINEHART KL
Citation: G. Faircloth et al., PRECLINICAL DEVELOPMENT OF APLIDINE, A NOVEL MARINE-DERIVED AGENT WITH POTENT ANTITUMOR-ACTIVITY, Annals of oncology, 9, 1998, pp. 129-129
INCOMPLETE CROSS-RESISTANCE BETWEEN ECTEINASCIDIN-743 (ET-743) AND STANDARD CHEMOTHERAPEUTIC-AGENTS AGAINST PRIMARY TUMORS IN HUMAN TUMOR CLONING ASSAY
Authors: IZBICKA E LAWRENCE R DAVIDSON K CERNA C GOMEZ L FAIRCLOTH GT JIMENO J WEITMAN S VONHOFF DD
Citation: E. Izbicka et al., INCOMPLETE CROSS-RESISTANCE BETWEEN ECTEINASCIDIN-743 (ET-743) AND STANDARD CHEMOTHERAPEUTIC-AGENTS AGAINST PRIMARY TUMORS IN HUMAN TUMOR CLONING ASSAY, Annals of oncology, 9, 1998, pp. 130-130
BIOANALYSIS OF APLIDINE, A NEW MARINE ANTITUMOR DEPSIPEPTIDE, IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AFTER DERIVATIZATION WITH4'-HYDRAZINO-2-STILBAZOLE
Authors: SPARIDANS RW HENRAR REC JIMENO J FAIRCLOTH C FLORIANO P BEIJNEN JH
Citation: Rw. Sparidans et al., BIOANALYSIS OF APLIDINE, A NEW MARINE ANTITUMOR DEPSIPEPTIDE, IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AFTER DERIVATIZATION WITH4'-HYDRAZINO-2-STILBAZOLE, Annals of oncology, 9, 1998, pp. 192-192
PHASE-I CLINICAL AND PHARMACOKINETIC (PK) STUDY OF ECTEINASCIDIN-743 (ET-743) GIVEN AS A ONE-HOUR INFUSION EVERY 21 DAYS
Authors: BOWMAN A TWELVES C HOEKMAN K SIMPSON A SMYTH J VERMORKEN J HOPPENER F BEIJNEN J VEGA E JIMENO J HANAUSKE AR
Citation: A. Bowman et al., PHASE-I CLINICAL AND PHARMACOKINETIC (PK) STUDY OF ECTEINASCIDIN-743 (ET-743) GIVEN AS A ONE-HOUR INFUSION EVERY 21 DAYS, Annals of oncology, 9, 1998, pp. 452-452
A PHASE-I AND PHARMACOKINETIC STUDY OF ET-743, A NOVEL DNA MINOR-GROOVE BINDER OF MARINE ORIGIN, ADMINISTERED AS A 1-HOUR INFUSION DAILY X 5 DAYS
Authors: VILLALONACALERO M ECKHARDT SG WEISS G CAMPBELL E HIDALGO M KRAYNAK M BEIJNEN J JIMENO J VONHOFF D ROWINSKY E
Citation: M. Villalonacalero et al., A PHASE-I AND PHARMACOKINETIC STUDY OF ET-743, A NOVEL DNA MINOR-GROOVE BINDER OF MARINE ORIGIN, ADMINISTERED AS A 1-HOUR INFUSION DAILY X 5 DAYS, Annals of oncology, 9, 1998, pp. 453-453
PHARMACOKINETICS OF ECTEINASCIDIN-743 (ET-743) IN 3 PHASE-I STUDIES
Authors: HILLEBRAND MJX JIMENO J CVITKOVIC E HOEKMAN K HOPPENER F TWELVES C VILLALONA M ROSING H BEIJNEN JH
Citation: Mjx. Hillebrand et al., PHARMACOKINETICS OF ECTEINASCIDIN-743 (ET-743) IN 3 PHASE-I STUDIES, Annals of oncology, 9, 1998, pp. 455-455
ECTEINASCIDIN-743 (ET-743) 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION (CI) PHASE-I STUDY IN SOLID TUMORS (ST) PATIENTS
Authors: CVITKOVIC E MEKRANTER B TAAMMA A GOLDWASSER F BEIJNEN JH JIMENO J RIOFRIO M VEGA E MISSET JL HOP P
Citation: E. Cvitkovic et al., ECTEINASCIDIN-743 (ET-743) 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION (CI) PHASE-I STUDY IN SOLID TUMORS (ST) PATIENTS, Annals of oncology, 9, 1998, pp. 456-456
IN-VITRO CYTOTOXICITY OF ECTEINASCIDIN-743 (ET-743) AGAINST HUMAN HEMATOPOIETIC PROGENITORS AND CANCER-CELLS
Authors: GHIELMINI M COLLI E ERBA E BERGAMOSCHI D JIMENO J FAIRCLOTH G SESSA C
Citation: M. Ghielmini et al., IN-VITRO CYTOTOXICITY OF ECTEINASCIDIN-743 (ET-743) AGAINST HUMAN HEMATOPOIETIC PROGENITORS AND CANCER-CELLS, Annals of oncology, 9, 1998, pp. 533-533
MODE OF ACTION OF ECTEINASCIDIN-743, A NATURAL MARINE COMPOUND WITH ANTITUMORAL ACTIVITY
Authors: ERBA E BERGAMASCHI D RONZONI S FARETTA M BASSANO L CAPPELLA P VALOTI G GIAVAZZI R JIMENO J FAIRCLOTH G DINCALCI M
Citation: E. Erba et al., MODE OF ACTION OF ECTEINASCIDIN-743, A NATURAL MARINE COMPOUND WITH ANTITUMORAL ACTIVITY, Annals of oncology, 9, 1998, pp. 535-535
THIOCORALINE, A NOVEL DNA-POLYMERASE INHIBITOR WITH A HIGHER CYTOTOXIC POTENCY AGAINST CANCER-CELLS WITH MUTATED OR INACTIVATED P53
Authors: ERBA E BERGAMASCHI D RONZONI S FARETTA M BASSANO L VIKHANSKAYA F JIMENO J FAIRCLOTH G CATAPANO CV DINCALCI M
Citation: E. Erba et al., THIOCORALINE, A NOVEL DNA-POLYMERASE INHIBITOR WITH A HIGHER CYTOTOXIC POTENCY AGAINST CANCER-CELLS WITH MUTATED OR INACTIVATED P53, Annals of oncology, 9, 1998, pp. 542-542
ANTIGENIC PROFILES OF ENDOTHELIAL AND HEMATOPOIETIC LINEAGES IN MURINE INTRAEMBRYONIC HEMOGENIC SITES
Authors: GARCIAPORRERO JA MANAIA A JIMENO J LASKY LL DIETERLENLIEVRE F GODIN IE
Citation: Ja. Garciaporrero et al., ANTIGENIC PROFILES OF ENDOTHELIAL AND HEMATOPOIETIC LINEAGES IN MURINE INTRAEMBRYONIC HEMOGENIC SITES, Developmental and comparative immunology, 22(3), 1998, pp. 303-319
IN-VITRO ACTIVITY OF APLIDINE, A NEW MARINE-DERIVED ANTICANCER COMPOUND, ON FRESHLY EXPLANTED CLONOGENIC HUMAN TUMOR-CELLS AND HEMATOPOIETIC PRECURSOR CELLS
Authors: DEPENBROCK H PETER R FAIRCLOTH GT MANZANARES I JIMENO J HANAUSKE AR
Citation: H. Depenbrock et al., IN-VITRO ACTIVITY OF APLIDINE, A NEW MARINE-DERIVED ANTICANCER COMPOUND, ON FRESHLY EXPLANTED CLONOGENIC HUMAN TUMOR-CELLS AND HEMATOPOIETIC PRECURSOR CELLS, British Journal of Cancer, 78(6), 1998, pp. 739-744
FLOW CYTOMETRIC ANALYSIS OF CELL-CYCLE PHASE PERTURBATIONS INDUCED BYTHIOCORALINE, A NEM MARINE-DERIVED ANTICANCER COMPOUND
Authors: BERGAMASCHI D FARETTA M RONZONI S TAVERNA S DEFEUDIS P BONFANTI M GUIDI G FAIRCLOTH M JIMENO J DINCALCI M ERBA E
Citation: D. Bergamaschi et al., FLOW CYTOMETRIC ANALYSIS OF CELL-CYCLE PHASE PERTURBATIONS INDUCED BYTHIOCORALINE, A NEM MARINE-DERIVED ANTICANCER COMPOUND, European journal of histochemistry, 41, 1997, pp. 63-64
BIOLOGICAL-ACTIVITY OF THIOCORALINE, A NOVEL MARINE DEPSIPEPTIDE
Authors: FAIRCLOTH G JIMENO J DINCALCI M
Citation: G. Faircloth et al., BIOLOGICAL-ACTIVITY OF THIOCORALINE, A NOVEL MARINE DEPSIPEPTIDE, European journal of cancer, 33, 1997, pp. 781-781
SCHEDULE-DEPENDENT MYELOTOXICITY INDUCED IN-VITRO BY THE NEW MARINE DERIVED MINOR-GROOVE INTERACTING AGENT ECTEINASCIDIN-743
Authors: GHIELMINI M COLLI E JIMENO J FAIRCLOTH G SESSA C
Citation: M. Ghielmini et al., SCHEDULE-DEPENDENT MYELOTOXICITY INDUCED IN-VITRO BY THE NEW MARINE DERIVED MINOR-GROOVE INTERACTING AGENT ECTEINASCIDIN-743, European journal of cancer, 33, 1997, pp. 807-807
PHASE-I AND PHARMACOKINETIC STUDY OF ECTEINASCIDIN-743 (ET-743) GIVENAS A ONE-HOUR INFUSION EVERY 21 DAYS
Authors: TWELVES CJ VERMORKEN J BOWMAN A SIMPSON A SMYTH J HOPPENER F BEIJNEN J JIMENO J HANAUSKE AR
Citation: Cj. Twelves et al., PHASE-I AND PHARMACOKINETIC STUDY OF ECTEINASCIDIN-743 (ET-743) GIVENAS A ONE-HOUR INFUSION EVERY 21 DAYS, European journal of cancer, 33, 1997, pp. 1107-1107
PHASE-I CLINICAL-STUDY OF ECTEINASCIDIN-743 (ET-743) AS A 24 HOURS CONTINUOUS INTRAVENOUS-INFUSION (CI) IN PATIENTS (PTS) WITH SOLID TUMORS(ST) - A PROGRESS REPORT
Authors: TAAMMA A CVITKOVIC E JIMENO J GASPARETTO M MEELEY K VEGA E CAMERON L MISSET JL
Citation: A. Taamma et al., PHASE-I CLINICAL-STUDY OF ECTEINASCIDIN-743 (ET-743) AS A 24 HOURS CONTINUOUS INTRAVENOUS-INFUSION (CI) IN PATIENTS (PTS) WITH SOLID TUMORS(ST) - A PROGRESS REPORT, European journal of cancer, 33, 1997, pp. 1119-1119
COMBINATION OF ORAL IDARUBICIN AND PREDNIMUSTINE IN ADVANCED BREAST-CANCER - A PHASE-II STUDY
Authors: BARNADAS A MENDIOLA C CASADO A VILLAR A JIMENO J CLERIGUE M ROSELL R DIAZRUBIO E CORTESFUNES H DEPAREDES MG
Citation: A. Barnadas et al., COMBINATION OF ORAL IDARUBICIN AND PREDNIMUSTINE IN ADVANCED BREAST-CANCER - A PHASE-II STUDY, European journal of cancer, 33(2), 1997, pp. 312-315
Risultati: 1-25 | 26-31